Terns Pharmaceuticals, Inc. (FRA:430)
Germany · Delayed Price · Currency is EUR 30.00
-2.00 (-6.25%)
At close: Jan 9, 2026
Terns Pharmaceuticals Market Cap
Terns Pharmaceuticals has a market cap or net worth of €3.32 billion as of January 9, 2026. Its market cap has increased by 584.83% in one year.
Market Cap
3.32B
Enterprise Value
3.06B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€30.00
Market Cap Chart
Since February 5, 2021, Terns Pharmaceuticals's market cap has increased from 119.38M to 3.32B, an increase of 2,678.98%. That is a compound annual growth rate of 96.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 3.32B | -11.35% |
| Dec 31, 2025 | 3.74B | 723.41% |
| Dec 31, 2024 | 454.52M | 25.27% |
| Dec 29, 2023 | 362.83M | -23.08% |
| Dec 30, 2022 | 471.66M | 200.27% |
| Dec 31, 2021 | 157.08M | 31.57% |
| Feb 5, 2021 | 119.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |